XLRN - Acceleron Pharma Inc

Healthcare - Sector

XLRN is currently covered by 17 analysts with average potential upside of $16.34 (24.21%) backed by 151 price targets and 161 ratings. Analyst's average stock valuation to be materialised ratio is 84.23% with an average time for price targets to be met of 215.47 days.

Most recent stock forecast was given by AKASH TEWARI from JEFFERIES on 08-Oct-2021.

Highest price target for XLRN is 179, Lowest price target is 116, average price target is 147.5.

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Hold

180

$1.25 (0.70%)

180

1 years 1 months 20 days ago

0/4 (0%)

$34.21 (26.40%)

Buy

1 years 1 months 23 days ago

15/15 (100%)

$33.83 (56.63%)

243

Hold

180

$1.25 (0.70%)

135

1 years 1 months 27 days ago

7/8 (87.5%)

$10.64 (15.70%)

88

Buy

180

$1.25 (0.70%)

148

1 years 1 months 27 days ago

8/9 (88.89%)

$23.84 (58.79%)

917

Buy

180

$1.25 (0.70%)

173

1 years 1 months 27 days ago

7/8 (87.5%)

$24.05 (30.44%)

174

Show more analysts

This chart will make you best informed on how analysts see your stock and which of them does well in less than two minutes.

28 days free trial

We do our best to collect, sort, and check every available news item on your stocks so that you can focus on what is important

For each analyst know for every call if it has been before or after the stock price moved

Understand how each analyst reacts to stock price movement

Get Started or Login